Clinical observation of combined treatment of low molecular weight heparin calcium and breviscapine in elder pulmonary heart disease
10.3969/j.issn.1671-8348.2014.20.016
- VernacularTitle:低分子肝素钙联合灯盏花素治疗老年肺心病疗效分析
- Author:
Zhangbai LI
;
Wei ZHONG
;
Xuemei LIAO
- Publication Type:Journal Article
- Keywords:
low molecular weight heparin calcium;
breviscapine;
elder pulmonary heart disease
- From:
Chongqing Medicine
2014;(20):2587-2588,2591
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the clinical therapeutic effect of combined treatment of low molecular weight heparin calcium and breviscapine in elder pulmonary heart disease .Methods 303 patients in elder pulmonary heart disease in the hospital from May 2011 to June 2013 were divided into three groups .100 patients in group A were received the routine therepy ,102 patients of group B were received routine therapy combined with low molecular weight heparin calcium only ,101 patients of group C were received routine therapy combined with low molecular weight heparin calcium and breviscapine .the changes of clinical symptom ,blood gas a-nalysis ,hemorheology in groups before and after treatment were observed .Results The effective rates of group A ,B ,C were 59 .0% ,73 .5% and 90 .0% ,the results showed that the blood gas analysis and hemorheology parameter in groups B and C had more improved than group A (P<0 .05) ,and better in group C than group B(P<0 .05) .Conclusion The combined treatment of low molecular weight heparin calcium and breviscapine can decrease the press of lung artery ,relieve the bear of right ventricle and improve the arterial partial pressure of oxygen ,mean pulmonary arterial pressure and hemorheology parameter ,and has less adverse reaction .
